Abstract |
|
Authors | Na Zhou, Congmin Liu, Helei Hou, Chuantao Zhang, Dong Liu, Guanqun Wang, Kewei Liu, Jingjuan Zhu, Hongying Lv, Tianjun Li, Xiaochun Zhang |
Journal | Oncotarget
(Oncotarget)
Vol. 7
Issue 44
Pg. 72373-72379
(11 01 2016)
ISSN: 1949-2553 [Electronic] United States |
PMID | 27738308
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Albumin-Bound Paclitaxel
- Antineoplastic Agents
- Biomarkers, Tumor
- Circulating Tumor DNA
- Protein Kinase Inhibitors
- Pyridines
- Bevacizumab
- Epirubicin
- apatinib
- Cyclophosphamide
- EGFR protein, human
- ErbB Receptors
- Receptors, Vascular Endothelial Growth Factor
- Cisplatin
|
Topics |
- Albumin-Bound Paclitaxel
(pharmacology, therapeutic use)
- Antineoplastic Agents
(therapeutic use)
- Antineoplastic Combined Chemotherapy Protocols
(pharmacology, therapeutic use)
- Bevacizumab
(pharmacology, therapeutic use)
- Biomarkers, Tumor
(analysis)
- Breast
(diagnostic imaging, pathology, surgery)
- Carcinoma
(diagnostic imaging, drug therapy, genetics, secondary)
- Chemotherapy, Adjuvant
(methods)
- Circulating Tumor DNA
(isolation & purification)
- Cisplatin
(pharmacology, therapeutic use)
- Cyclophosphamide
(pharmacology, therapeutic use)
- Disease Progression
- Drug Resistance, Neoplasm
- Epirubicin
(pharmacology, therapeutic use)
- ErbB Receptors
(genetics, metabolism)
- Female
- Hand-Foot Syndrome
(etiology)
- High-Throughput Nucleotide Sequencing
- Humans
- Hypertension
(chemically induced)
- Lung Neoplasms
(diagnostic imaging, drug therapy, genetics, secondary)
- Mastectomy, Modified Radical
- Middle Aged
- Mutation
- Neovascularization, Pathologic
(drug therapy)
- Positron Emission Tomography Computed Tomography
- Protein Kinase Inhibitors
(therapeutic use)
- Pyridines
(therapeutic use)
- Receptors, Vascular Endothelial Growth Factor
(genetics, metabolism)
- Sequence Analysis, DNA
(methods)
- Thoracic Neoplasms
(diagnostic imaging, drug therapy, genetics, secondary)
- Treatment Failure
- Triple Negative Breast Neoplasms
(drug therapy, genetics, pathology, surgery)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|